Cargando…

VHH selected against the viral spike protein can protect mice against lethal rabies virus challenge

Detalles Bibliográficos
Autores principales:	Rosseels, Valérie, Vanlandschoot, Peter, Hultberg, Anna, Verrips, Theo, Saunders, Michael, de Haard, Hans, Francart, Aurélie, Kalai, Michael M, Van Gucht, Steven
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019449/

Ejemplares similares

Protective Effect of Different Anti-Rabies Virus VHH Constructs against Rabies Disease in Mice
por: Terryn, Sanne, et al.
Publicado: (2014)

Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection
por: Terryn, Sanne, et al.
Publicado: (2016)

Lactobacillli expressing llama VHH fragments neutralise Lactococcus phages
por: Hultberg, Anna, et al.
Publicado: (2007)

Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules
por: Hultberg, Anna, et al.
Publicado: (2011)

Enhancement of Polymeric Immunoglobulin Receptor Transcytosis by Biparatopic VHH
por: Emmerson, Chris D., et al.
Publicado: (2011)

VHH-Photosensitizer Conjugates for Targeted Photodynamic Therapy of Met-Overexpressing Tumor Cells
por: Heukers, Raimond, et al.
Publicado: (2019)

Impact of caspase-1/11, -3, -7, or IL-1β/IL-18 deficiency on rabies virus-induced macrophage cell death and onset of disease
por: Kip, E, et al.
Publicado: (2017)

A Two-Step Lyssavirus Real-Time Polymerase Chain Reaction Using Degenerate Primers with Superior Sensitivity to the Fluorescent Antigen Test
por: Suin, Vanessa, et al.
Publicado: (2014)

Construction of a camelid VHH yeast two-hybrid library and the selection of VHH against haemagglutinin-neuraminidase protein of the Newcastle disease virus
por: Gao, Xiaolong, et al.
Publicado: (2016)

Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
por: Strokappe, Nika M., et al.
Publicado: (2019)

Against Orthodoxies in Rabies
por: Greval, S. D. S.
Publicado: (1936)

Against Orthodoxies in Rabies
Publicado: (1936)

Rabies Virus Antibodies from Oral Vaccination as a Correlate of Protection against Lethal Infection in Wildlife
por: Moore, Susan M., et al.
Publicado: (2017)

GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery
por: van Schie, Loes, et al.
Publicado: (2023)

Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca naïve phage display library
por: Li, Qianlin, et al.
Publicado: (2022)

Serum Treatment against Rabies
por: Shewan, G. M.
Publicado: (1897)

Biting back against rabies
Publicado: (2010)

Search for Resonant and Non-Resonant VHH Production
por: Kyriacou, Nicholas Graves
Publicado: (2022)

Effective vaccination against rabies in puppies in rabies endemic regions
por: Morters, M. K., et al.
Publicado: (2015)

State of Globe: Rabies: The Lethality Since Antiquity!
por: Maurya, Inder, et al.
Publicado: (2015)

A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition
por: Lutje Hulsik, David, et al.
Publicado: (2013)

A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 determinant for neutralization but not for antigen recognition
por: Weissenhorn, W, et al.
Publicado: (2012)

MALT1 Controls Attenuated Rabies Virus by Inducing Early Inflammation and T Cell Activation in the Brain
por: Kip, E., et al.
Publicado: (2018)

VHH Antibodies: Reagents for Mycotoxin Detection in Food Products
por: Wang, Jia, et al.
Publicado: (2018)

VHH-Based Bispecific Antibodies Targeting Cytokine Production
por: Nosenko, Maxim A., et al.
Publicado: (2017)

Molecular recognition requires dimerization of a VHH antibody
por: Smith, Christopher A., et al.
Publicado: (2023)

FULLY AI-DRIVEN HUMANOID VHH PHAGE LIBRARY
por: Zhao, Yangyang, et al.
Publicado: (2023)

Development of VHH Antibodies against Dengue Virus Type 2 NS1 and Comparison with Monoclonal Antibodies for Use in Immunological Diagnosis
por: Fatima, Aneela, et al.
Publicado: (2014)

First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants
por: Titong, Allison, et al.
Publicado: (2022)

Rabies DNA vaccine: No impact of MHC Class I and Class II targeting sequences on immune response and protection against lethal challenge
por: Kaur, Manpreet, et al.
Publicado: (2009)

Intracerebral delivery of small interfering RNAs (siRNAs) using adenoviral vector protects mice against lethal peripheral rabies challenge
por: Gupta, Praveen K., et al.
Publicado: (2012)

Protection of Mice Against Lethal Rabies Virus Challenge Using Short Interfering RNAs (siRNAs) Delivered Through Lentiviral Vector
por: Singh, Niraj K., et al.
Publicado: (2013)

Self-Assembling VHH-Elastin-Like Peptides for Photodynamic Nanomedicine
por: Pille, Jan, et al.
Publicado: (2017)

Peptide Linker Affecting the Activity Retention Rate of VHH in Immunosorbents
por: Li, Da, et al.
Publicado: (2020)

Increasing the melting temperature of VHH with the in silico free energy score
por: Tomimoto, Yusuke, et al.
Publicado: (2023)

Development in Immunoprophylaxis against Rabies for Animals and Humans
por: Nandi, Sukdeb, et al.
Publicado: (2010)

The path towards effective antivirals against rabies
por: Jochmans, Dirk, et al.
Publicado: (2019)

Co-lethality studied as an asset against viral drug escape: the HIV protease case
por: Brouillet, Sophie, et al.
Publicado: (2010)

Selection of Nanobodies that Target Human Neonatal Fc Receptor
por: Andersen, Jan Terje, et al.
Publicado: (2013)

The Activity of Rabies Vaccines against Genetic Clusters of Rabies Virus Circulating at the Territory of Ukraine
por: Ivanov, Mykola, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_me92b6nqjl0ihafcu301e4riif